Progress report: the carcinoid syndrome.
D006916:5-Hydroxytryptophan / Q000652:urine; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001920:Bradykinin / Q000097:blood; D003967:Diarrhea / Q000188:drug therapy / Q000209:etiology; D006349:Heart Valve Diseases / Q000150:complications; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000652:urine; D007610:Kallikreins / Q000378:metabolism; D008113:Liver Neoplasms / Q000209:etiology; D008303:Malignant Carcinoid Syndrome / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery; D008750:Methyldopa / Q000627:therapeutic use; D008784:Methysergide / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D010643:Phenoxybenzamine / Q000627:therapeutic use; D010649:Phenylalanine / Q000627:therapeutic use; D012701:Serotonin / Q000652:urine
D000970:Antineoplastic Agents; D010643:Phenoxybenzamine; D012701:Serotonin; D010649:Phenylalanine; D006897:Hydroxyindoleacetic Acid; D008750:Methyldopa; D006916:5-Hydroxytryptophan; D007610:Kallikreins; D001920:Bradykinin; D008784:Methysergide